Land: Verenigd Koninkrijk
Taal: Engels
Bron: MHRA (Medicines & Healthcare Products Regulatory Agency)
Chlorhexidine gluconate
Boston Healthcare Ltd
A01AB03
Chlorhexidine gluconate
5mg/1gram
Cutaneous gel
Cutaneous
No Controlled Drug Status
Valid as a prescribable product
BNF: 13100500; GTIN: 5050768030066
_Colours_ _(Printed)_ _Title:_ _Ref:_ _Date:_ _Modified:_ _Size:_ Cepton Clear Gel PIL CEP/BOST/CG 17/10/12 13/12/12 180(W) x 150(H) Side 1 Black _Colours_ _(Non printed)_ TRIM PACKAGE LEAFLET: INFORMATION FOR THE USER CEPTON MEDICATED CLEAR GEL CHLORHEXIDINE GLUCONATE READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. Always use Cepton Medicated Clear Gel exactly as described in this leaflet or as your doctor or pharmacist has told you. • Keep this leaflet. You may need to read it again. • Ask your pharmacist if you need more information or advice. • If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. • You must talk to your doctor if your condition does not improve or gets worse. IN THIS LEAFLET: 1. What Cepton Medicated Clear Gel is and what it is used for 2. What you need to know before you use Cepton Medicated Clear Gel 3. How to use Cepton Medicated Clear Gel 4. Possible side effects 5. How to store Cepton Medicated Clear Gel 6. Contents of the pack and other information 1. WHAT CEPTON MEDICATED CLEAR GEL IS AND WHAT IT IS USED FOR 2. WHAT YOU NEED TO KNOW BEFORE YOU USE CEPTON MEDICATED CLEAR GEL Cepton Medicated Clear Gel contains the active ingredient chlorhexidine gluconate, which is an antiseptic that kills harmful bacteria on the skin and so helps to treat spots and acne. Acne is a common condition where tiny holes (pores) on the surface of the skin become blocked causing spots to develop, usually on the face, back and chest. The spots can range from whiteheads and blackheads to red, inflamed pus-filled spots and cysts. DO NOT USE CEPTON MEDICATED CLEAR GEL if you are allergic (hypersensitive) to chlorhexidine gluconate or any of the other ingredients of Cepton Medicated Clear Gel (see section 6). WARNINGS AND PRECAUTIONS • Cepton Medicated Clear Gel should only be used on your skin. • Do not let it get into your eyes. Treat accidental spla Lees het volledige document
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Acnemed Clear 0.5% w/w Gel Cepton Medicated Clear Gel 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Active ingredient: Chlorhexidine Gluconate 0.5%w/w (incorporated as Chlorhexidine Gluconate Solution BP 2.5% V/W. 3 PHARMACEUTICAL FORM Gel. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS An aid in the treatment of spots and acne. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION For topical use only. Apply morning and night as follows: wash hands and face apply a thin coating of the gel to the affected area and work in thoroughly. 4.3 CONTRAINDICATIONS Known hypersensitivity to any of the constituents. 4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE For external use only. If symptoms persist or skin irritation occurs, consult your doctor or pharmacist. Avoid contact with eyes. Keep all medicines out of the reach and sight of children. Consult your doctor or pharmacist before using this medicinal product if you are pregnant or breast-feeding. Flammable 4.5 INTERACTION WITH OTHER MEDICINAL PRODUCTS AND OTHER FORMS OF INTERACTION There are no known interactions with other medications. 4.6 FERTILITY, PREGNANCY AND LACTATION The product is not contra-indicated during pregnancy and lactation. However, as with all medicines during pregnancy, caution should be exercised. Consult your doctor or pharmacist before use. 4.7 EFFECTS ON ABILITY TO DRIVE AND USE MACHINES The ability to drive or use machines is not affected. 4.8 UNDESIRABLE EFFECTS Local irritation, skin rashes and other skin reactions such as contact dermatitis have been reported. Anaphylactic allergic reactions have been reported. REPORTING OF SUSPECTED ADVERSE REACTIONS Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard. 4.9 OVERDOSE Accidenta Lees het volledige document